-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

SCI-39 The Immune System and Progression from Precursor Condition to Active Myeloma

Program: Scientific Program
Session: The Immune System in Multiple Myeloma
Monday, December 7, 2020, 11:25 AM-11:30 AM

Kyohei Nakamura, MD, PhD

QIMR Berghofer Medical Research Institute, Herston, Australia

Disclosures: Nakamura: Bristol Myers Squibb: Research Funding; Tizona Therapeutics: Research Funding; Compass Therapeutics: Consultancy; Tizona Therapeutics: Consultancy.

See more of: The Immune System in Multiple Myeloma
See more of: Scientific Program
Previous Presentation | Next Presentation >>